Colossally Cool Cannabinoids Captivate Creo, Genomatica, Amyris, Others

February 15, 2021

Print This Article Share it With Friends

by Helena Tavares Kennedy (Biofuels Digest) ... From California’s Creo becoming the first company to achieve demo scale production of rare cannabinoid CBGA in partnership with Genomatica, to Amyris’s expansion of consumer brands by launching a new range of Terasana products using cannabinoids, we dive into what is making cannabinoids so captivating for 2021.

In today’s Digest, the latest news from around the world on cannabinoids, how some are making cannabinoids without even using the cannabis plant, a new market report on cannabinoids, and more.

...

According to a recent report on cannabinoids and the bio revolution by Raymond James, a financial services firm, the global market for cannabinoids produced by fermentation is estimated to grow from $10 billion in 2025 to $115 billion by 2040.

And a new Nova Institute report said the market potential for CBD and other cannabinoids is huge now that cannabis is removed from the United Nations prohibition schedule and CBD is not considered a narcotic drug. The 142-page report “Production of Cannabinoids via Extraction, Chemical Synthesis and Especially Biotechnology – Current Technologies, Potential & Drawbacks and Future Development” provides in-depth information on established and emerging biotechnological approaches on the production of cannabinoids, as well as an overview on the state-of-the-art production methods using plant extraction and chemical synthesis. Additionally, 59 companies active in cannabinoid production are listed, from which 20 specialized in biotechnological production and chemical synthesis are described in detail. More info on the Nova Institute report can be found here.

Check out this slide guide from December that looks at Flavors, Fragrances and Cannabinoids on how others are cracking into the exploding markets in cannabinoids.

Bottom Line

So hemp is hot, but cannabinoids are compelling and are going to be big in 2021 with all these latest milestones in research, commercialization and consumer products. It’s being touted for asthma, for a range of anti-inflammatory and anti-bacterial benefits, and more, so we only see this area growing even more as health becomes more of a focus factor for many during these crazy covid times. READ MORE

Amyris Delivers Record Production Of CBG For Consumer Skincare Formulations (Amyris)

The cannabinoid revolution is coming – and fermentation is the catalyst (Biofuels Digest/Creo)